Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine-n-butyl bromide for progress of labour
PACTR201908521430230Not yet recruiting
- Sponsor
- Fagbohun
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in labor dysfunction comparing Hyoscine-n-butyl bromide with Placebo (2 arms). Primary endpoint: Duration of active phase of labour. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
hyoscine butylbromide
03
Conditions
labor dysfunction
Beyond the preview
Go deeper on PACTR201908521430230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201908521430230.